NASDAQ: PFSA · Industrial Applications and Services · 7 alerts · CIK 1859807
Share price
$0.4057Close, Nov 16
Market cap
$246K
Shares outstanding
605.65KLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Profusa, Inc. filings on SEC EDGAR ↗
Profusa, Inc. reported a net loss of $17.2 million for the nine months ended September 30, 2026, an improvement from the $31.2 million loss in the prior year period. The company's balance sheet was significantly impacted by the issuance of a $28.3 million G3 call option asset and the settlement of various liabilities through the issuance of Series A non-voting convertible preferred stock.
Profusa $2.5M Debt Financing with NorthView Sponsor I LLC
Profusa, Inc. entered into a fourth amendment to its Note Modification and Conversion Agreement with NorthView Sponsor I LLC regarding a $2.5 million promissory note. The amendment adjusts the conversion price to the greater of $0.20 or the closing price on the trading day preceding a conversion notice, while maintaining a 122% multiplier on the principal amount being converted. This modification follows several previous amendments to the debt instrument's conversion terms throughout 2026.
Profusa $769K Debt Financing with Ascent Partners Fund LLC
Profusa, Inc. issued a Senior Secured Convertible Promissory Note to Ascent Partners Fund LLC with a principal amount of $769,230.77 for a purchase price of $700,000. The note matures in October 2027, bears 7% annual interest, and is convertible into common stock at an initial price of $4.28 per share.
Profusa Debt Financing Update with Ascent Partners Fund LLC
Profusa, Inc. entered into amendments with Ascent Partners Fund LLC regarding two senior secured convertible promissory notes totaling approximately $1.67 million in principal. The amendments modify the conversion price mechanics to the greater of $1.20 or 95% of the lowest daily VWAP, establish a fixed floor price of $0.338 per share, and include a waiver of certain anti-dilution provisions for other outstanding notes.
Profusa, Inc. stockholders approved an amendment to the Certificate of Incorporation to authorize the Board of Directors to effect one or more reverse stock splits at a ratio between 1-for-2 and 1-for-12. The Board has the discretion to implement these splits over the next two years, provided the aggregate ratio does not exceed 1-for-12.
Profusa Debt Financing Update with Ascent Partners Fund LLC
Profusa, Inc. issued a senior secured convertible promissory note to Ascent Partners Fund LLC with a principal amount of $384,615.38 for a purchase price of $350,000. The note bears 7% interest, matures in September 2027, and is secured by substantially all of the company's assets. It is convertible into common stock at a price of $4.28 per share, subject to a floor price of $1.07.
Profusa, Inc. received a letter from Nasdaq confirming it has regained compliance with the minimum bid price and stockholders' equity requirements. As a result, the company will be subject to a one-year Mandatory Panel Monitor period, during which any further non-compliance with the equity rule will result in a prompt delisting determination without a cure period. The company intends to continue monitoring its status to maintain its listing on The Nasdaq Capital Market.